Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
NCT05091385
·
clinicaltrials.gov ↗
COMPLETED
Status
106
Enrollment
OTHER
Sponsor class
Conditions
Asthma; Eosinophilic
Interventions
BIOLOGICAL:
Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019
Sponsor
Medical University of Lodz
Collaborators
[object Object]